| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| beta-Lactamases | 100 | 2024 | 192 | 23.160 |
Why?
|
| Escherichia coli | 57 | 2024 | 988 | 8.740 |
Why?
|
| beta-Lactamase Inhibitors | 28 | 2023 | 55 | 8.030 |
Why?
|
| Bacterial Proteins | 45 | 2024 | 885 | 7.200 |
Why?
|
| Ceftazidime | 18 | 2024 | 41 | 4.880 |
Why?
|
| Anti-Bacterial Agents | 41 | 2024 | 2416 | 4.740 |
Why?
|
| Models, Molecular | 49 | 2023 | 1075 | 4.140 |
Why?
|
| Catalytic Domain | 22 | 2025 | 157 | 4.080 |
Why?
|
| Carbapenems | 11 | 2023 | 35 | 3.460 |
Why?
|
| Peptide Library | 14 | 2021 | 56 | 3.410 |
Why?
|
| Klebsiella pneumoniae | 8 | 2024 | 73 | 2.980 |
Why?
|
| beta-Lactam Resistance | 14 | 2020 | 46 | 2.900 |
Why?
|
| Norovirus | 11 | 2025 | 316 | 2.820 |
Why?
|
| Escherichia coli Proteins | 8 | 2023 | 305 | 2.550 |
Why?
|
| Amino Acid Substitution | 19 | 2024 | 393 | 2.450 |
Why?
|
| Cephalosporins | 13 | 2023 | 138 | 2.440 |
Why?
|
| Kinetics | 36 | 2021 | 1321 | 2.400 |
Why?
|
| Drug Resistance, Bacterial | 8 | 2023 | 363 | 2.280 |
Why?
|
| Hydrolysis | 24 | 2024 | 163 | 2.240 |
Why?
|
| Amino Acid Sequence | 43 | 2021 | 2699 | 2.210 |
Why?
|
| Protein Binding | 37 | 2021 | 1749 | 2.090 |
Why?
|
| Microbial Sensitivity Tests | 29 | 2024 | 786 | 1.850 |
Why?
|
| Substrate Specificity | 23 | 2023 | 290 | 1.770 |
Why?
|
| beta-Lactams | 14 | 2023 | 50 | 1.760 |
Why?
|
| Mutagenesis, Site-Directed | 24 | 2020 | 317 | 1.630 |
Why?
|
| Crystallography, X-Ray | 16 | 2023 | 357 | 1.580 |
Why?
|
| Penicillins | 9 | 2023 | 154 | 1.500 |
Why?
|
| Streptomyces | 7 | 2021 | 14 | 1.490 |
Why?
|
| Ampicillin | 11 | 2023 | 58 | 1.460 |
Why?
|
| High-Throughput Nucleotide Sequencing | 6 | 2020 | 870 | 1.450 |
Why?
|
| Mutation | 25 | 2024 | 5809 | 1.380 |
Why?
|
| Enzyme Inhibitors | 12 | 2015 | 578 | 1.350 |
Why?
|
| Evolution, Molecular | 8 | 2020 | 672 | 1.300 |
Why?
|
| Single-Chain Antibodies | 4 | 2020 | 43 | 1.290 |
Why?
|
| Caliciviridae Infections | 8 | 2025 | 328 | 1.270 |
Why?
|
| Molecular Sequence Data | 42 | 2017 | 3873 | 1.180 |
Why?
|
| Catalysis | 12 | 2023 | 126 | 1.150 |
Why?
|
| Protein Structure, Tertiary | 14 | 2023 | 756 | 1.120 |
Why?
|
| Bacillus anthracis | 6 | 2017 | 39 | 1.080 |
Why?
|
| Protein Conformation | 16 | 2021 | 833 | 1.070 |
Why?
|
| Treponema pallidum | 8 | 2008 | 49 | 1.050 |
Why?
|
| Polymyxins | 2 | 2023 | 14 | 1.050 |
Why?
|
| Imipenem | 4 | 2023 | 9 | 1.000 |
Why?
|
| Mutagenesis | 15 | 2023 | 347 | 0.980 |
Why?
|
| Mutation, Missense | 5 | 2020 | 868 | 0.980 |
Why?
|
| Colistin | 2 | 2023 | 30 | 0.970 |
Why?
|
| Binding Sites | 25 | 2020 | 1296 | 0.950 |
Why?
|
| Bacteriophages | 3 | 2020 | 77 | 0.940 |
Why?
|
| Cefotaxime | 7 | 2023 | 35 | 0.940 |
Why?
|
| Mutant Proteins | 5 | 2012 | 112 | 0.930 |
Why?
|
| Glycine | 4 | 2016 | 168 | 0.920 |
Why?
|
| Drug Resistance, Multiple, Bacterial | 3 | 2020 | 134 | 0.890 |
Why?
|
| Cell Surface Display Techniques | 2 | 2020 | 8 | 0.890 |
Why?
|
| Enzyme Stability | 10 | 2018 | 58 | 0.870 |
Why?
|
| Antibodies, Viral | 4 | 2020 | 1149 | 0.830 |
Why?
|
| Thermodynamics | 12 | 2020 | 144 | 0.820 |
Why?
|
| Drug Resistance, Microbial | 10 | 2023 | 192 | 0.810 |
Why?
|
| Cloning, Molecular | 16 | 2020 | 892 | 0.800 |
Why?
|
| Virion | 4 | 2017 | 148 | 0.800 |
Why?
|
| Drug Resistance | 1 | 2023 | 256 | 0.790 |
Why?
|
| Peptides | 5 | 2013 | 793 | 0.790 |
Why?
|
| Base Sequence | 27 | 2016 | 3094 | 0.750 |
Why?
|
| Genes, fos | 2 | 2020 | 16 | 0.740 |
Why?
|
| Suppression, Genetic | 3 | 2010 | 43 | 0.740 |
Why?
|
| Antigens, Viral | 2 | 2020 | 437 | 0.730 |
Why?
|
| Small Molecule Libraries | 2 | 2020 | 124 | 0.730 |
Why?
|
| Penicillin-Binding Proteins | 3 | 2020 | 14 | 0.720 |
Why?
|
| Antigens, Bacterial | 8 | 2012 | 313 | 0.710 |
Why?
|
| Genes, jun | 1 | 2020 | 8 | 0.710 |
Why?
|
| Recombinant Proteins | 12 | 2020 | 1393 | 0.700 |
Why?
|
| Protons | 1 | 2020 | 91 | 0.690 |
Why?
|
| Gastroenteritis | 4 | 2025 | 348 | 0.690 |
Why?
|
| Protein Interaction Maps | 1 | 2020 | 78 | 0.680 |
Why?
|
| Plasmids | 13 | 2020 | 514 | 0.660 |
Why?
|
| Protein Engineering | 3 | 2016 | 73 | 0.650 |
Why?
|
| Structure-Activity Relationship | 20 | 2021 | 572 | 0.650 |
Why?
|
| Biological Assay | 1 | 2020 | 100 | 0.640 |
Why?
|
| Protein Array Analysis | 5 | 2014 | 101 | 0.630 |
Why?
|
| Cephalosporin Resistance | 1 | 2018 | 17 | 0.620 |
Why?
|
| Protein Interaction Mapping | 3 | 2020 | 84 | 0.610 |
Why?
|
| Protease Inhibitors | 5 | 2025 | 94 | 0.610 |
Why?
|
| Urinary Tract Infections | 1 | 2022 | 300 | 0.580 |
Why?
|
| Zinc | 2 | 2012 | 127 | 0.560 |
Why?
|
| Nucleotide Motifs | 1 | 2016 | 43 | 0.550 |
Why?
|
| Serine | 2 | 2016 | 173 | 0.540 |
Why?
|
| Amino Acids | 5 | 2024 | 663 | 0.540 |
Why?
|
| Streptococcus pyogenes | 5 | 2020 | 77 | 0.520 |
Why?
|
| Nuclear Receptor Coactivator 3 | 5 | 2016 | 348 | 0.480 |
Why?
|
| Staphylococcus aureus | 3 | 2021 | 459 | 0.480 |
Why?
|
| Biological Evolution | 2 | 2015 | 224 | 0.480 |
Why?
|
| Bacteriophage M13 | 4 | 2011 | 18 | 0.470 |
Why?
|
| Asparagine | 2 | 2011 | 22 | 0.470 |
Why?
|
| Periplasmic Proteins | 2 | 2011 | 6 | 0.460 |
Why?
|
| Sequence Analysis, DNA | 8 | 2016 | 1762 | 0.460 |
Why?
|
| Open Reading Frames | 7 | 2020 | 210 | 0.460 |
Why?
|
| Genes, Bacterial | 9 | 2020 | 209 | 0.450 |
Why?
|
| Gene Library | 9 | 2012 | 220 | 0.430 |
Why?
|
| Genomic Library | 4 | 2020 | 39 | 0.430 |
Why?
|
| Binding Sites, Antibody | 3 | 2020 | 98 | 0.430 |
Why?
|
| Ampicillin Resistance | 6 | 2012 | 17 | 0.420 |
Why?
|
| Klebsiella Infections | 3 | 2023 | 52 | 0.420 |
Why?
|
| Virology | 1 | 2013 | 31 | 0.420 |
Why?
|
| Arginine | 2 | 2019 | 330 | 0.410 |
Why?
|
| Protein Structure, Secondary | 7 | 2020 | 238 | 0.400 |
Why?
|
| Clinical Laboratory Techniques | 1 | 2013 | 141 | 0.390 |
Why?
|
| Acylation | 4 | 2021 | 16 | 0.390 |
Why?
|
| Orotidine-5'-Phosphate Decarboxylase | 1 | 2011 | 3 | 0.390 |
Why?
|
| Cysteine | 1 | 2012 | 135 | 0.380 |
Why?
|
| Antibodies, Monoclonal | 6 | 2020 | 1015 | 0.380 |
Why?
|
| Sequence Alignment | 7 | 2020 | 625 | 0.370 |
Why?
|
| Gram-Positive Bacteria | 2 | 2020 | 46 | 0.360 |
Why?
|
| Selection, Genetic | 3 | 2012 | 155 | 0.360 |
Why?
|
| Gram-Negative Bacteria | 2 | 2020 | 67 | 0.360 |
Why?
|
| Molecular Structure | 9 | 2024 | 290 | 0.350 |
Why?
|
| Monobactams | 2 | 2023 | 5 | 0.350 |
Why?
|
| Nuclear Receptor Coactivator 1 | 4 | 2015 | 241 | 0.330 |
Why?
|
| Antibodies, Bacterial | 6 | 2012 | 386 | 0.330 |
Why?
|
| Protein Interaction Domains and Motifs | 3 | 2020 | 137 | 0.330 |
Why?
|
| Protein Domains | 3 | 2020 | 234 | 0.330 |
Why?
|
| DNA, Bacterial | 11 | 2014 | 475 | 0.330 |
Why?
|
| Drug Discovery | 2 | 2021 | 172 | 0.330 |
Why?
|
| Gene Expression Regulation, Bacterial | 3 | 2011 | 157 | 0.330 |
Why?
|
| Protein Structure, Quaternary | 4 | 2015 | 98 | 0.320 |
Why?
|
| Rabbits | 8 | 2020 | 711 | 0.320 |
Why?
|
| Peptide Hydrolases | 4 | 2023 | 141 | 0.320 |
Why?
|
| Shewanella | 4 | 2010 | 8 | 0.320 |
Why?
|
| Genetic Vectors | 8 | 2020 | 940 | 0.320 |
Why?
|
| Codon | 4 | 2018 | 96 | 0.320 |
Why?
|
| Virus Replication | 3 | 2025 | 610 | 0.310 |
Why?
|
| Genome, Bacterial | 6 | 2008 | 184 | 0.310 |
Why?
|
| Sequence Homology, Amino Acid | 6 | 2020 | 657 | 0.310 |
Why?
|
| Proline | 2 | 2008 | 77 | 0.310 |
Why?
|
| Epitopes | 4 | 2020 | 432 | 0.300 |
Why?
|
| DNA Primers | 7 | 2015 | 660 | 0.300 |
Why?
|
| DNA | 3 | 2023 | 1599 | 0.300 |
Why?
|
| Proteome | 3 | 2008 | 241 | 0.300 |
Why?
|
| Penicillanic Acid | 4 | 2004 | 9 | 0.290 |
Why?
|
| Serratia marcescens | 1 | 2007 | 10 | 0.290 |
Why?
|
| Humans | 48 | 2025 | 124404 | 0.280 |
Why?
|
| Glutathione Transferase | 2 | 2005 | 153 | 0.280 |
Why?
|
| Leucine | 1 | 2008 | 310 | 0.280 |
Why?
|
| Cephalexin | 2 | 2021 | 7 | 0.280 |
Why?
|
| Syphilis | 3 | 2008 | 96 | 0.270 |
Why?
|
| Transcription Factors | 5 | 2014 | 2607 | 0.270 |
Why?
|
| Ligands | 4 | 2017 | 536 | 0.270 |
Why?
|
| Gene Expression | 5 | 2020 | 1569 | 0.270 |
Why?
|
| Cephalothin | 2 | 2020 | 6 | 0.270 |
Why?
|
| Streptococcal Infections | 3 | 2020 | 244 | 0.260 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 9 | 2015 | 816 | 0.260 |
Why?
|
| Epitope Mapping | 3 | 2020 | 78 | 0.260 |
Why?
|
| Alanine | 6 | 2009 | 181 | 0.250 |
Why?
|
| Protein Folding | 3 | 2001 | 218 | 0.250 |
Why?
|
| Virulence Factors | 2 | 2020 | 176 | 0.240 |
Why?
|
| Glutamic Acid | 3 | 2015 | 201 | 0.240 |
Why?
|
| Rotavirus | 3 | 2014 | 496 | 0.230 |
Why?
|
| Azabicyclo Compounds | 1 | 2024 | 16 | 0.220 |
Why?
|
| Morpholines | 1 | 2024 | 55 | 0.220 |
Why?
|
| Viral Vaccines | 2 | 2025 | 334 | 0.220 |
Why?
|
| Biocatalysis | 2 | 2015 | 33 | 0.220 |
Why?
|
| Pseudomonas aeruginosa | 1 | 2005 | 167 | 0.210 |
Why?
|
| Biology | 1 | 2023 | 29 | 0.210 |
Why?
|
| Cross Reactions | 2 | 2014 | 193 | 0.210 |
Why?
|
| Drug Combinations | 1 | 2024 | 266 | 0.210 |
Why?
|
| Hydrogen-Ion Concentration | 4 | 2019 | 426 | 0.210 |
Why?
|
| Protein Sorting Signals | 3 | 2011 | 38 | 0.210 |
Why?
|
| Enzymes | 1 | 2003 | 52 | 0.210 |
Why?
|
| Aspartic Acid | 2 | 2001 | 74 | 0.200 |
Why?
|
| Feces | 3 | 2015 | 717 | 0.200 |
Why?
|
| Host-Pathogen Interactions | 1 | 2025 | 254 | 0.200 |
Why?
|
| Enterobacter cloacae | 3 | 2015 | 12 | 0.200 |
Why?
|
| Capsid Proteins | 2 | 2020 | 182 | 0.200 |
Why?
|
| Combinatorial Chemistry Techniques | 1 | 2002 | 14 | 0.200 |
Why?
|
| Quantum Theory | 1 | 2021 | 15 | 0.190 |
Why?
|
| Genome, Viral | 2 | 2020 | 168 | 0.190 |
Why?
|
| Gram-Positive Bacterial Infections | 1 | 2002 | 76 | 0.190 |
Why?
|
| Promoter Regions, Genetic | 2 | 2008 | 1341 | 0.190 |
Why?
|
| Antibodies | 2 | 2020 | 371 | 0.180 |
Why?
|
| Phylogeny | 4 | 2023 | 696 | 0.180 |
Why?
|
| Cefazolin | 1 | 2021 | 20 | 0.180 |
Why?
|
| Genomics | 2 | 2008 | 1490 | 0.180 |
Why?
|
| Protein Conformation, beta-Strand | 1 | 2020 | 16 | 0.180 |
Why?
|
| Protein Conformation, alpha-Helical | 1 | 2020 | 16 | 0.180 |
Why?
|
| Bacterial Outer Membrane Proteins | 5 | 2010 | 107 | 0.180 |
Why?
|
| Animals | 22 | 2021 | 34145 | 0.180 |
Why?
|
| Lac Repressors | 1 | 2020 | 14 | 0.180 |
Why?
|
| Arabinose | 1 | 2000 | 25 | 0.180 |
Why?
|
| Molecular Dynamics Simulation | 2 | 2021 | 104 | 0.180 |
Why?
|
| Leucine Zippers | 1 | 2020 | 16 | 0.180 |
Why?
|
| Repressor Proteins | 4 | 2019 | 820 | 0.180 |
Why?
|
| Macrocyclic Compounds | 1 | 2020 | 10 | 0.180 |
Why?
|
| Pharyngitis | 1 | 2020 | 31 | 0.170 |
Why?
|
| Vimentin | 1 | 2020 | 66 | 0.170 |
Why?
|
| Peptidomimetics | 1 | 2020 | 11 | 0.170 |
Why?
|
| P-Selectin | 1 | 2020 | 77 | 0.170 |
Why?
|
| Colorimetry | 1 | 2020 | 15 | 0.170 |
Why?
|
| Endotoxemia | 1 | 2020 | 58 | 0.170 |
Why?
|
| DNA-Binding Proteins | 1 | 2008 | 2055 | 0.170 |
Why?
|
| Disseminated Intravascular Coagulation | 1 | 2020 | 67 | 0.170 |
Why?
|
| Peptide Fragments | 3 | 2007 | 749 | 0.170 |
Why?
|
| Cell Adhesion | 1 | 2020 | 319 | 0.170 |
Why?
|
| Neisseria gonorrhoeae | 1 | 2019 | 15 | 0.170 |
Why?
|
| Biosensing Techniques | 1 | 2020 | 53 | 0.160 |
Why?
|
| Antiviral Agents | 1 | 2025 | 746 | 0.160 |
Why?
|
| Leukocytes | 1 | 2020 | 206 | 0.160 |
Why?
|
| Drug Design | 1 | 2020 | 146 | 0.160 |
Why?
|
| Calorimetry | 4 | 2014 | 61 | 0.160 |
Why?
|
| rho GTP-Binding Proteins | 1 | 2019 | 68 | 0.160 |
Why?
|
| Nuclear Receptor Coactivator 2 | 3 | 2015 | 202 | 0.160 |
Why?
|
| Histidine | 1 | 2019 | 72 | 0.160 |
Why?
|
| Conserved Sequence | 2 | 2016 | 293 | 0.160 |
Why?
|
| Saccharomyces cerevisiae | 4 | 1994 | 426 | 0.160 |
Why?
|
| Viral Nonstructural Proteins | 2 | 2012 | 191 | 0.150 |
Why?
|
| Phenylalanine | 1 | 1999 | 124 | 0.150 |
Why?
|
| Epistasis, Genetic | 1 | 2018 | 93 | 0.150 |
Why?
|
| Molecular Imaging | 1 | 2018 | 61 | 0.150 |
Why?
|
| Terminology as Topic | 1 | 2020 | 225 | 0.150 |
Why?
|
| Membrane Glycoproteins | 1 | 2020 | 412 | 0.150 |
Why?
|
| Staphylococcal Infections | 2 | 2021 | 556 | 0.150 |
Why?
|
| MAP Kinase Signaling System | 1 | 2019 | 316 | 0.150 |
Why?
|
| Apoenzymes | 1 | 2017 | 3 | 0.140 |
Why?
|
| Benzimidazoles | 2 | 2016 | 132 | 0.140 |
Why?
|
| Proteolysis | 2 | 2019 | 169 | 0.140 |
Why?
|
| Glutathione | 1 | 2018 | 194 | 0.140 |
Why?
|
| Proteins | 1 | 2003 | 1044 | 0.140 |
Why?
|
| Oximes | 1 | 2017 | 50 | 0.140 |
Why?
|
| DNA Mutational Analysis | 3 | 2012 | 788 | 0.140 |
Why?
|
| Aztreonam | 1 | 1996 | 4 | 0.140 |
Why?
|
| Aeromonas hydrophila | 1 | 2016 | 3 | 0.140 |
Why?
|
| Microfilament Proteins | 1 | 2019 | 274 | 0.140 |
Why?
|
| Carcinogenesis | 1 | 2019 | 334 | 0.140 |
Why?
|
| Polymerase Chain Reaction | 5 | 2015 | 1584 | 0.130 |
Why?
|
| Cross Infection | 1 | 2020 | 331 | 0.130 |
Why?
|
| Oligopeptides | 1 | 2016 | 117 | 0.130 |
Why?
|
| Tyrosine | 2 | 2015 | 152 | 0.130 |
Why?
|
| Molecular Conformation | 3 | 2025 | 101 | 0.130 |
Why?
|
| Hydrogen Bonding | 4 | 2012 | 79 | 0.130 |
Why?
|
| Hydrazones | 1 | 2016 | 19 | 0.130 |
Why?
|
| Temperature | 2 | 2010 | 304 | 0.130 |
Why?
|
| Point Mutation | 1 | 2017 | 348 | 0.130 |
Why?
|
| Polymorphism, Genetic | 2 | 2008 | 810 | 0.130 |
Why?
|
| Reproducibility of Results | 3 | 2020 | 2874 | 0.130 |
Why?
|
| Proteus Infections | 1 | 1995 | 7 | 0.120 |
Why?
|
| Proteus mirabilis | 1 | 1995 | 12 | 0.120 |
Why?
|
| Iodides | 1 | 2015 | 16 | 0.120 |
Why?
|
| DNA, Viral | 1 | 2016 | 479 | 0.120 |
Why?
|
| Betaherpesvirinae | 1 | 2015 | 5 | 0.120 |
Why?
|
| Endangered Species | 1 | 2015 | 10 | 0.120 |
Why?
|
| Thrombosis | 1 | 2020 | 519 | 0.120 |
Why?
|
| Antibodies, Anti-Idiotypic | 1 | 2015 | 43 | 0.120 |
Why?
|
| GATA2 Transcription Factor | 1 | 2014 | 46 | 0.120 |
Why?
|
| Trichothecenes | 1 | 2014 | 4 | 0.120 |
Why?
|
| Genotype | 2 | 2019 | 2552 | 0.110 |
Why?
|
| Elephants | 1 | 2015 | 40 | 0.110 |
Why?
|
| DNA, Fungal | 3 | 1991 | 75 | 0.110 |
Why?
|
| Nuclear Receptor Coactivators | 1 | 2014 | 72 | 0.110 |
Why?
|
| Solubility | 2 | 2012 | 132 | 0.110 |
Why?
|
| Models, Chemical | 2 | 2004 | 86 | 0.110 |
Why?
|
| Bufanolides | 1 | 2014 | 17 | 0.110 |
Why?
|
| HeLa Cells | 4 | 2018 | 809 | 0.110 |
Why?
|
| Herpesviridae Infections | 1 | 2015 | 142 | 0.110 |
Why?
|
| Protein Stability | 2 | 2011 | 165 | 0.110 |
Why?
|
| Antineoplastic Agents, Phytogenic | 1 | 2014 | 101 | 0.110 |
Why?
|
| Autism Spectrum Disorder | 1 | 2019 | 393 | 0.110 |
Why?
|
| Water | 2 | 2012 | 184 | 0.110 |
Why?
|
| Nucleoside-Triphosphatase | 1 | 2012 | 3 | 0.100 |
Why?
|
| Nerve Tissue Proteins | 1 | 2019 | 1114 | 0.100 |
Why?
|
| Carboxylic Acids | 1 | 2012 | 24 | 0.100 |
Why?
|
| Anthrax Vaccines | 1 | 2012 | 26 | 0.100 |
Why?
|
| Enterobacteriaceae | 1 | 1992 | 35 | 0.100 |
Why?
|
| Viral Proteins | 1 | 2014 | 348 | 0.100 |
Why?
|
| Mutation Rate | 1 | 2012 | 66 | 0.100 |
Why?
|
| Down-Regulation | 2 | 2011 | 701 | 0.100 |
Why?
|
| Metalloendopeptidases | 1 | 2012 | 100 | 0.100 |
Why?
|
| Gossypol | 1 | 2011 | 3 | 0.100 |
Why?
|
| Methicillin-Resistant Staphylococcus aureus | 1 | 2014 | 221 | 0.100 |
Why?
|
| Thiazoles | 1 | 2012 | 97 | 0.100 |
Why?
|
| Dose-Response Relationship, Drug | 3 | 2021 | 1688 | 0.100 |
Why?
|
| Exotoxins | 1 | 2011 | 44 | 0.100 |
Why?
|
| Norwalk virus | 1 | 2013 | 170 | 0.100 |
Why?
|
| Receptors, Androgen | 1 | 2014 | 412 | 0.090 |
Why?
|
| Cell Line, Tumor | 5 | 2019 | 3342 | 0.090 |
Why?
|
| Models, Genetic | 3 | 2010 | 759 | 0.090 |
Why?
|
| Cyclic GMP-Dependent Protein Kinases | 1 | 2011 | 14 | 0.090 |
Why?
|
| Cyclic GMP | 1 | 2011 | 91 | 0.090 |
Why?
|
| Stereoisomerism | 2 | 2024 | 105 | 0.090 |
Why?
|
| Mice | 10 | 2020 | 17728 | 0.090 |
Why?
|
| Cyclic AMP | 1 | 2011 | 248 | 0.090 |
Why?
|
| DNA Replication | 2 | 1991 | 350 | 0.090 |
Why?
|
| Sensitivity and Specificity | 2 | 2013 | 2031 | 0.080 |
Why?
|
| Biomarkers | 1 | 2018 | 2980 | 0.080 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 2 | 2015 | 314 | 0.080 |
Why?
|
| Transcription, Genetic | 5 | 2016 | 1701 | 0.080 |
Why?
|
| Inhibitory Concentration 50 | 2 | 2011 | 77 | 0.080 |
Why?
|
| RNA | 1 | 2012 | 568 | 0.080 |
Why?
|
| Electrophoretic Mobility Shift Assay | 1 | 2008 | 49 | 0.080 |
Why?
|
| Microbial Viability | 1 | 2008 | 42 | 0.080 |
Why?
|
| Regulon | 1 | 2008 | 10 | 0.070 |
Why?
|
| RNA-Binding Proteins | 1 | 2012 | 577 | 0.070 |
Why?
|
| Interferometry | 2 | 2020 | 26 | 0.070 |
Why?
|
| Laminin | 1 | 2008 | 70 | 0.070 |
Why?
|
| Fibronectins | 1 | 2008 | 104 | 0.070 |
Why?
|
| Molecular Docking Simulation | 2 | 2020 | 112 | 0.070 |
Why?
|
| Bacterial Physiological Phenomena | 1 | 2007 | 17 | 0.070 |
Why?
|
| Antibody Specificity | 1 | 2007 | 202 | 0.070 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 2 | 2008 | 1015 | 0.070 |
Why?
|
| Multiprotein Complexes | 1 | 2008 | 207 | 0.070 |
Why?
|
| Gene Transfer, Horizontal | 1 | 2007 | 43 | 0.070 |
Why?
|
| Toxins, Biological | 1 | 2007 | 69 | 0.070 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2015 | 1288 | 0.070 |
Why?
|
| Clavulanic Acid | 2 | 2004 | 6 | 0.070 |
Why?
|
| Gene Amplification | 2 | 2008 | 228 | 0.070 |
Why?
|
| beta Karyopherins | 1 | 2006 | 12 | 0.070 |
Why?
|
| Genes, Fungal | 1 | 1986 | 63 | 0.070 |
Why?
|
| Nuclear Pore Complex Proteins | 1 | 2006 | 11 | 0.070 |
Why?
|
| Recombinant Fusion Proteins | 2 | 2000 | 767 | 0.070 |
Why?
|
| Movement | 1 | 2007 | 170 | 0.060 |
Why?
|
| Neoplasms | 3 | 2015 | 2801 | 0.060 |
Why?
|
| Signal Transduction | 3 | 2014 | 4535 | 0.060 |
Why?
|
| Glycoproteins | 1 | 2007 | 369 | 0.060 |
Why?
|
| DNA, Recombinant | 2 | 2000 | 100 | 0.060 |
Why?
|
| Crystallography | 1 | 2025 | 40 | 0.060 |
Why?
|
| Gene Duplication | 1 | 2007 | 358 | 0.060 |
Why?
|
| Proteomics | 1 | 2008 | 491 | 0.060 |
Why?
|
| Electron Spin Resonance Spectroscopy | 1 | 2004 | 22 | 0.060 |
Why?
|
| In Vitro Techniques | 1 | 2006 | 969 | 0.060 |
Why?
|
| Esters | 1 | 2024 | 30 | 0.060 |
Why?
|
| Spin Labels | 1 | 2004 | 39 | 0.060 |
Why?
|
| Chemistry, Pharmaceutical | 1 | 2024 | 46 | 0.060 |
Why?
|
| Bacteria | 2 | 2002 | 485 | 0.060 |
Why?
|
| MCF-7 Cells | 2 | 2015 | 222 | 0.060 |
Why?
|
| Spectrophotometry | 1 | 2004 | 59 | 0.060 |
Why?
|
| Amino Acid Motifs | 1 | 2004 | 200 | 0.060 |
Why?
|
| Chelating Agents | 1 | 2004 | 42 | 0.060 |
Why?
|
| Ribosomal Proteins | 1 | 2004 | 73 | 0.050 |
Why?
|
| Cell Nucleus | 1 | 2006 | 677 | 0.050 |
Why?
|
| Peroxidases | 1 | 1983 | 26 | 0.050 |
Why?
|
| Catalase | 1 | 1983 | 50 | 0.050 |
Why?
|
| Computational Biology | 1 | 2008 | 820 | 0.050 |
Why?
|
| Anthrax | 1 | 2003 | 30 | 0.050 |
Why?
|
| Directed Molecular Evolution | 1 | 2003 | 11 | 0.050 |
Why?
|
| Disulfides | 1 | 2003 | 78 | 0.050 |
Why?
|
| Indicators and Reagents | 1 | 2003 | 51 | 0.050 |
Why?
|
| Protein Processing, Post-Translational | 2 | 2016 | 355 | 0.050 |
Why?
|
| Sequence Deletion | 1 | 2005 | 528 | 0.050 |
Why?
|
| Gene Deletion | 3 | 2012 | 795 | 0.050 |
Why?
|
| Drug Delivery Systems | 1 | 2004 | 185 | 0.050 |
Why?
|
| Superoxide Dismutase | 1 | 1983 | 139 | 0.050 |
Why?
|
| Solvents | 1 | 2022 | 42 | 0.050 |
Why?
|
| Lysine | 1 | 2003 | 197 | 0.050 |
Why?
|
| Child | 2 | 2022 | 24526 | 0.050 |
Why?
|
| Sulbactam | 2 | 2000 | 5 | 0.050 |
Why?
|
| Antineoplastic Agents | 1 | 2011 | 1674 | 0.050 |
Why?
|
| Chromosomes, Artificial, Bacterial | 1 | 2002 | 93 | 0.050 |
Why?
|
| Gene Expression Profiling | 2 | 2008 | 1695 | 0.050 |
Why?
|
| Surface Plasmon Resonance | 2 | 2014 | 46 | 0.050 |
Why?
|
| X-Ray Diffraction | 1 | 2001 | 96 | 0.050 |
Why?
|
| Gram-Negative Bacterial Infections | 1 | 2002 | 87 | 0.050 |
Why?
|
| Multigene Family | 2 | 2008 | 297 | 0.050 |
Why?
|
| Cell Survival | 2 | 2015 | 806 | 0.050 |
Why?
|
| Iron | 1 | 2004 | 267 | 0.050 |
Why?
|
| Methicillin | 1 | 2021 | 43 | 0.050 |
Why?
|
| Isoenzymes | 1 | 2001 | 228 | 0.050 |
Why?
|
| Latin America | 1 | 2021 | 89 | 0.050 |
Why?
|
| Complement Inactivator Proteins | 1 | 2000 | 3 | 0.040 |
Why?
|
| AraC Transcription Factor | 1 | 2000 | 2 | 0.040 |
Why?
|
| Genetic Engineering | 1 | 2021 | 163 | 0.040 |
Why?
|
| Penicillin G | 1 | 2000 | 19 | 0.040 |
Why?
|
| Mass Spectrometry | 1 | 2001 | 331 | 0.040 |
Why?
|
| Endothelium | 1 | 2020 | 72 | 0.040 |
Why?
|
| Macaca fascicularis | 1 | 2020 | 86 | 0.040 |
Why?
|
| Human Umbilical Vein Endothelial Cells | 1 | 2020 | 85 | 0.040 |
Why?
|
| Healthy Volunteers | 1 | 2020 | 133 | 0.040 |
Why?
|
| Enzyme Activation | 1 | 2021 | 624 | 0.040 |
Why?
|
| raf Kinases | 1 | 2019 | 7 | 0.040 |
Why?
|
| Diagnostic Tests, Routine | 1 | 2021 | 117 | 0.040 |
Why?
|
| Taurodeoxycholic Acid | 1 | 2019 | 4 | 0.040 |
Why?
|
| 3T3 Cells | 1 | 2019 | 129 | 0.040 |
Why?
|
| Fibrin | 1 | 2020 | 66 | 0.040 |
Why?
|
| Chenodeoxycholic Acid | 1 | 2019 | 13 | 0.040 |
Why?
|
| Disease Models, Animal | 2 | 2020 | 4355 | 0.040 |
Why?
|
| Blotting, Western | 3 | 2014 | 1108 | 0.040 |
Why?
|
| Computer Simulation | 3 | 2012 | 643 | 0.040 |
Why?
|
| International Cooperation | 1 | 2020 | 157 | 0.040 |
Why?
|
| Post-Synaptic Density | 1 | 2019 | 11 | 0.040 |
Why?
|
| Terminator Regions, Genetic | 1 | 1998 | 7 | 0.040 |
Why?
|
| Female | 9 | 2020 | 66305 | 0.040 |
Why?
|
| Intracellular Space | 1 | 2018 | 48 | 0.040 |
Why?
|
| Rec A Recombinases | 1 | 1998 | 26 | 0.040 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 1 | 2019 | 158 | 0.040 |
Why?
|
| Consensus | 1 | 2022 | 629 | 0.040 |
Why?
|
| von Willebrand Factor | 1 | 2020 | 195 | 0.040 |
Why?
|
| Mice, Nude | 1 | 2019 | 710 | 0.040 |
Why?
|
| Drosophila melanogaster | 1 | 1983 | 771 | 0.040 |
Why?
|
| Oxidation-Reduction | 1 | 2018 | 445 | 0.040 |
Why?
|
| United States | 1 | 2013 | 10773 | 0.040 |
Why?
|
| Cytoskeletal Proteins | 1 | 2019 | 269 | 0.040 |
Why?
|
| Microscopy, Confocal | 1 | 2018 | 348 | 0.040 |
Why?
|
| Fluorescent Dyes | 1 | 2018 | 261 | 0.040 |
Why?
|
| Cell Proliferation | 2 | 2014 | 2304 | 0.030 |
Why?
|
| Virus Attachment | 1 | 2016 | 41 | 0.030 |
Why?
|
| Immunoglobulin G | 2 | 2015 | 772 | 0.030 |
Why?
|
| Membrane Proteins | 1 | 2004 | 1529 | 0.030 |
Why?
|
| Surface Properties | 1 | 1996 | 83 | 0.030 |
Why?
|
| Male | 7 | 2020 | 61028 | 0.030 |
Why?
|
| Cell Line | 2 | 2014 | 2770 | 0.030 |
Why?
|
| Cyclohexanones | 1 | 2015 | 19 | 0.030 |
Why?
|
| Cells, Cultured | 1 | 2021 | 3052 | 0.030 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2019 | 534 | 0.030 |
Why?
|
| Interferons | 1 | 2016 | 123 | 0.030 |
Why?
|
| Drug Screening Assays, Antitumor | 1 | 2015 | 94 | 0.030 |
Why?
|
| Autistic Disorder | 1 | 2019 | 349 | 0.030 |
Why?
|
| Polysaccharides | 1 | 2016 | 142 | 0.030 |
Why?
|
| Chromatography, Gel | 1 | 2015 | 96 | 0.030 |
Why?
|
| Virosomes | 1 | 2014 | 4 | 0.030 |
Why?
|
| Antibody Affinity | 1 | 2014 | 39 | 0.030 |
Why?
|
| Immunoblotting | 1 | 2015 | 313 | 0.030 |
Why?
|
| Enterobacteriaceae Infections | 1 | 2015 | 55 | 0.030 |
Why?
|
| MutS DNA Mismatch-Binding Protein | 1 | 2014 | 9 | 0.030 |
Why?
|
| Hepatocyte Nuclear Factor 3-alpha | 1 | 2014 | 49 | 0.030 |
Why?
|
| Endoplasmic Reticulum Stress | 1 | 2015 | 121 | 0.030 |
Why?
|
| Threonine | 1 | 1994 | 59 | 0.030 |
Why?
|
| Tumor Burden | 1 | 2015 | 229 | 0.030 |
Why?
|
| DNA Transposable Elements | 2 | 1992 | 177 | 0.030 |
Why?
|
| Enzyme Precursors | 1 | 1994 | 22 | 0.030 |
Why?
|
| Immunoglobulin M | 1 | 2015 | 211 | 0.030 |
Why?
|
| Immunoglobulin A | 1 | 2015 | 207 | 0.030 |
Why?
|
| Methionine | 1 | 1994 | 103 | 0.030 |
Why?
|
| Enzyme Induction | 1 | 1994 | 103 | 0.030 |
Why?
|
| Protein-Arginine N-Methyltransferases | 1 | 2014 | 41 | 0.030 |
Why?
|
| p300-CBP Transcription Factors | 1 | 2014 | 44 | 0.030 |
Why?
|
| Receptors, Peptide | 1 | 1994 | 49 | 0.030 |
Why?
|
| Pyridines | 1 | 2015 | 229 | 0.030 |
Why?
|
| Digoxin | 1 | 2014 | 41 | 0.030 |
Why?
|
| RNA Interference | 1 | 2015 | 503 | 0.030 |
Why?
|
| Bacterial Adhesion | 1 | 1994 | 108 | 0.030 |
Why?
|
| Enhancer Elements, Genetic | 1 | 2014 | 295 | 0.030 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2015 | 236 | 0.030 |
Why?
|
| HEK293 Cells | 1 | 2015 | 753 | 0.030 |
Why?
|
| Genome-Wide Association Study | 1 | 2020 | 1660 | 0.030 |
Why?
|
| Inflammation | 1 | 2020 | 1414 | 0.030 |
Why?
|
| Escherichia coli Infections | 1 | 2014 | 196 | 0.030 |
Why?
|
| Sequence Homology | 1 | 1992 | 63 | 0.030 |
Why?
|
| Bacillus | 1 | 1992 | 35 | 0.030 |
Why?
|
| Mice, SCID | 1 | 2014 | 571 | 0.030 |
Why?
|
| Crystallization | 1 | 2012 | 83 | 0.030 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2015 | 887 | 0.030 |
Why?
|
| Reactive Oxygen Species | 1 | 2015 | 492 | 0.020 |
Why?
|
| Genetic Variation | 1 | 2019 | 1492 | 0.020 |
Why?
|
| Rats | 1 | 2019 | 3687 | 0.020 |
Why?
|
| Leupeptins | 1 | 2011 | 26 | 0.020 |
Why?
|
| Replicon | 1 | 1991 | 6 | 0.020 |
Why?
|
| DNA, Circular | 1 | 1991 | 18 | 0.020 |
Why?
|
| MAP Kinase Kinase 1 | 1 | 2011 | 39 | 0.020 |
Why?
|
| Proteasome Inhibitors | 1 | 2011 | 61 | 0.020 |
Why?
|
| Cystic Fibrosis | 1 | 2014 | 257 | 0.020 |
Why?
|
| Serotyping | 2 | 2002 | 178 | 0.020 |
Why?
|
| Random Allocation | 1 | 1992 | 436 | 0.020 |
Why?
|
| Cyclic AMP-Dependent Protein Kinase RIalpha Subunit | 1 | 2011 | 5 | 0.020 |
Why?
|
| Apoproteins | 1 | 2011 | 20 | 0.020 |
Why?
|
| Structural Homology, Protein | 1 | 2011 | 26 | 0.020 |
Why?
|
| Gene Expression Regulation | 1 | 2000 | 2534 | 0.020 |
Why?
|
| Chromatin | 1 | 2014 | 554 | 0.020 |
Why?
|
| Drug Synergism | 1 | 2011 | 232 | 0.020 |
Why?
|
| Cyclic GMP-Dependent Protein Kinase Type I | 1 | 2011 | 15 | 0.020 |
Why?
|
| Cyclic AMP Receptor Protein | 1 | 2010 | 1 | 0.020 |
Why?
|
| Virulence | 1 | 2011 | 262 | 0.020 |
Why?
|
| Macaca mulatta | 1 | 2012 | 493 | 0.020 |
Why?
|
| Lac Operon | 1 | 2010 | 95 | 0.020 |
Why?
|
| beta-Galactosidase | 1 | 2010 | 145 | 0.020 |
Why?
|
| Heme | 1 | 2010 | 53 | 0.020 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2011 | 266 | 0.020 |
Why?
|
| Mice, Inbred BALB C | 1 | 2012 | 1006 | 0.020 |
Why?
|
| Oxidative Stress | 1 | 2015 | 813 | 0.020 |
Why?
|
| Neoplasm Proteins | 1 | 2014 | 669 | 0.020 |
Why?
|
| Genes, Reporter | 1 | 2010 | 383 | 0.020 |
Why?
|
| Bacterial Infections | 1 | 1992 | 306 | 0.020 |
Why?
|
| Guanidine | 2 | 2001 | 10 | 0.020 |
Why?
|
| Protein Denaturation | 2 | 2001 | 50 | 0.020 |
Why?
|
| Hydrophobic and Hydrophilic Interactions | 1 | 2008 | 57 | 0.020 |
Why?
|
| Two-Hybrid System Techniques | 1 | 2008 | 66 | 0.020 |
Why?
|
| Treponemal Infections | 1 | 2008 | 3 | 0.020 |
Why?
|
| Hot Temperature | 1 | 2008 | 136 | 0.020 |
Why?
|
| Microscopy, Immunoelectron | 1 | 2008 | 25 | 0.020 |
Why?
|
| Aerobiosis | 1 | 2008 | 14 | 0.020 |
Why?
|
| Anaerobiosis | 1 | 2008 | 13 | 0.020 |
Why?
|
| Quality Control | 1 | 2008 | 119 | 0.020 |
Why?
|
| DNA Fingerprinting | 1 | 2008 | 107 | 0.020 |
Why?
|
| Operon | 1 | 2008 | 52 | 0.020 |
Why?
|
| Estrogen Receptor alpha | 1 | 2011 | 467 | 0.020 |
Why?
|
| Bacterial Vaccines | 1 | 2008 | 100 | 0.020 |
Why?
|
| Vaccines, Subunit | 1 | 2008 | 67 | 0.020 |
Why?
|
| Flagella | 1 | 2007 | 28 | 0.020 |
Why?
|
| Bacillus subtilis | 1 | 2007 | 48 | 0.020 |
Why?
|
| Oxygen | 1 | 2010 | 554 | 0.020 |
Why?
|
| Species Specificity | 1 | 2008 | 548 | 0.020 |
Why?
|
| Microscopy, Fluorescence | 1 | 2008 | 328 | 0.020 |
Why?
|
| Genes, Regulator | 1 | 1986 | 56 | 0.020 |
Why?
|
| Active Transport, Cell Nucleus | 1 | 2006 | 117 | 0.020 |
Why?
|
| Sequence Homology, Nucleic Acid | 1 | 1986 | 286 | 0.020 |
Why?
|
| Serine-Type D-Ala-D-Ala Carboxypeptidase | 1 | 2005 | 4 | 0.020 |
Why?
|
| Prognosis | 1 | 2014 | 4554 | 0.020 |
Why?
|
| Chromosome Mapping | 1 | 2008 | 1082 | 0.020 |
Why?
|
| RNA, Bacterial | 1 | 2005 | 54 | 0.020 |
Why?
|
| Chromosome Deletion | 1 | 1988 | 647 | 0.010 |
Why?
|
| Buffers | 1 | 2004 | 31 | 0.010 |
Why?
|
| Dimethyl Sulfoxide | 1 | 2004 | 18 | 0.010 |
Why?
|
| Freezing | 1 | 2004 | 28 | 0.010 |
Why?
|
| Solutions | 1 | 2004 | 65 | 0.010 |
Why?
|
| Breast Neoplasms | 1 | 2016 | 2508 | 0.010 |
Why?
|
| Amitrole | 1 | 1983 | 2 | 0.010 |
Why?
|
| Pupa | 1 | 1983 | 21 | 0.010 |
Why?
|
| Hydrogen Peroxide | 1 | 1983 | 113 | 0.010 |
Why?
|
| Streptococcal Vaccines | 1 | 2002 | 17 | 0.010 |
Why?
|
| Larva | 1 | 1983 | 248 | 0.010 |
Why?
|
| Immune Sera | 1 | 2002 | 95 | 0.010 |
Why?
|
| Hemolysis | 1 | 2002 | 110 | 0.010 |
Why?
|
| Periplasm | 1 | 2001 | 8 | 0.010 |
Why?
|
| Immunization | 1 | 2002 | 307 | 0.010 |
Why?
|
| Phenotype | 1 | 2010 | 4255 | 0.010 |
Why?
|
| Inclusion Bodies | 1 | 2001 | 48 | 0.010 |
Why?
|
| Young Adult | 1 | 2014 | 8979 | 0.010 |
Why?
|
| Circular Dichroism | 1 | 2000 | 86 | 0.010 |
Why?
|
| Flow Cytometry | 1 | 2002 | 802 | 0.010 |
Why?
|
| Middle Aged | 2 | 2000 | 26460 | 0.010 |
Why?
|
| Sex Factors | 1 | 1983 | 1267 | 0.010 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2008 | 2615 | 0.010 |
Why?
|
| Adult | 2 | 2014 | 29397 | 0.010 |
Why?
|
| RNA, Messenger | 1 | 2005 | 2824 | 0.010 |
Why?
|
| Helicobacter pylori | 1 | 2007 | 1320 | 0.010 |
Why?
|
| Isomerism | 1 | 1996 | 31 | 0.010 |
Why?
|
| Guanidines | 1 | 1996 | 25 | 0.010 |
Why?
|
| Aging | 1 | 1983 | 1184 | 0.010 |
Why?
|
| Spectrometry, Fluorescence | 1 | 1996 | 87 | 0.010 |
Why?
|
| Carrier Proteins | 1 | 2000 | 1024 | 0.010 |
Why?
|
| Receptors, Mating Factor | 1 | 1994 | 2 | 0.010 |
Why?
|
| Mating Factor | 1 | 1994 | 4 | 0.010 |
Why?
|
| Hemagglutination Tests | 1 | 1994 | 11 | 0.010 |
Why?
|
| Adhesins, Escherichia coli | 1 | 1994 | 20 | 0.010 |
Why?
|
| Genetic Complementation Test | 1 | 1994 | 87 | 0.010 |
Why?
|
| Fimbriae, Bacterial | 1 | 1994 | 42 | 0.010 |
Why?
|
| Oligonucleotides | 1 | 1994 | 89 | 0.010 |
Why?
|
| Sheep | 1 | 1994 | 212 | 0.010 |
Why?
|
| Fungal Proteins | 1 | 1994 | 134 | 0.010 |
Why?
|
| GTP-Binding Proteins | 1 | 1994 | 171 | 0.010 |
Why?
|
| Cytoplasm | 1 | 1994 | 291 | 0.010 |
Why?
|
| Transformation, Genetic | 1 | 1991 | 35 | 0.010 |
Why?
|
| Chromosomes, Fungal | 1 | 1991 | 49 | 0.010 |
Why?
|
| Restriction Mapping | 1 | 1991 | 188 | 0.010 |
Why?
|
| Polymorphism, Restriction Fragment Length | 1 | 1991 | 143 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2000 | 6470 | 0.010 |
Why?
|
| Infant | 1 | 2000 | 12479 | 0.000 |
Why?
|
| Child, Preschool | 1 | 2000 | 14085 | 0.000 |
Why?
|
| Aged | 1 | 2000 | 19479 | 0.000 |
Why?
|
| Adolescent | 1 | 2000 | 19358 | 0.000 |
Why?
|